More than 60% of all pharmaceutical target proteins and the majority of all new pharmaceuticals and vaccines, are protein-based. In research and development, and production of these protein-based therapeutics, finding the optimal conditions for protein production is often a time-consuming and laborious process. Xbrane Biopharma has two tightly-controlled bacterial protein expression systems. They enable expression of host-toxic and challenging proteins, as well as high yields of soluble proteins.
- Bli medlem
- Om SwedenBIO